GSA Capital Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,247
| Closed | -$249K | – | 2046 |
|
|
2022
Q3 | $249K | Sell |
30,247
-3,163
| -9% | -$26K | 0.03% | 1057 |
|
|
2022
Q2 | $219K | Buy |
+33,410
| New | +$219K | 0.03% | 1031 |
|
|
2021
Q4 | – | Sell |
-35,232
| Closed | -$218K | – | 1977 |
|
|
2021
Q3 | $218K | Buy |
+35,232
| New | +$218K | 0.02% | 1197 |
|
|
2020
Q3 | – | Sell |
-33,447
| Closed | -$172K | – | 1479 |
|
|
2020
Q2 | $172K | Sell |
33,447
-57,525
| -63% | -$296K | 0.1% | 385 |
|
|
2020
Q1 | $329K | Buy |
90,972
+9,673
| +12% | +$35K | 0.08% | 426 |
|
|
2019
Q4 | $508K | Buy |
81,299
+68,764
| +549% | +$430K | 0.06% | 636 |
|
|
2019
Q3 | $106K | Sell |
12,535
-8,512
| -40% | -$72K | 0.01% | 1271 |
|
|
2019
Q2 | $142K | Sell |
21,047
-47,796
| -69% | -$322K | 0.02% | 1298 |
|
|
2019
Q1 | $565K | Buy |
+68,843
| New | +$565K | 0.06% | 620 |
|
|
2017
Q4 | – | Sell |
-1,470
| Closed | -$54K | – | 1936 |
|
|
2017
Q3 | $54K | Buy |
+1,470
| New | +$54K | ﹤0.01% | 1547 |
|